New research, published in the British Journal of Nutrition, presented the results of three human studies performed to explore the physiological benefits of Palatinose.
Source: I Holub et al., “Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose),” British Journal of Nutrition, published online March 9, 2010.
Palatinose is a disaccharide carbohydrate derived from sucrose by Beneo (Morris Plains, NJ). Its linkage between glucose and fructose units is different from that of sugar (alpha-1,6-glucosidic instead of alpha-1,2-glucosidic in sucrose). Earlier enzyme kinetic studies have shown that the linkage in Palatinose is more slowly digested by the enzymes of the small intestine than the linkage in sugars such as sucrose and maltose. New research, published in the British Journal of Nutrition, presented the results of three human studies performed to explore the physiological benefits of Palatinose.
The first study examined whether Palatinose is fully digestible and available when consumed from foods and beverages in humans. Researchers found that Palatinose is fully digested and absorbed from the small intestine, regardless of whether consumed in food or beverage.
A second study explored whether the slow release of Palatinose led to complete digestion and absorption, and how this is reflected in blood glucose response. A three-hour blood glucose test was administered on healthy adult subjects. Palatinose subjects indicated significantly lower blood glucose and insulin response compared to sucrose. Palatinose was fully digested and absorbed in the small intestine.
A third study, a double-blind, controlled design, evaluated what the acceptance and tolerance of Palatinose consumption is over a longer period of time in human metabolism, compared to sucrose. Subjects with raised blood lipids consumed 50 g of Palatinose or sucrose every day for four weeks. Researchers found that Palatinose is well tolerated and had no detrimental effects on blood lipids (including cholesterol and low-density lipoprotein cholesterol) or cardiovascular risk markers. Moreover, carbohydrate-metabolism parameters, such as fasting blood glucose levels and insulin resistance, were significantly reduced after four weeks of Palatinose consumption. Researchers said that no such significant difference was observed with sucrose.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.